Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-957-4 | CAS number: 112-31-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1980-10-13 to 1980-12-15
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The study meets generally accepted scientific standards with acceptable restrictions for the standard test.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: Clive D, Spector JFS (1975). Laboratory procedures for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutation Research Vol 31 pp 17-29.
- Principles of method if other than guideline:
- Mouse lymphoma assay
- GLP compliance:
- no
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Nonanal
- EC Number:
- 204-688-5
- EC Name:
- Nonanal
- Cas Number:
- 124-19-6
- Molecular formula:
- C9H18O
- IUPAC Name:
- nonanal
- Details on test material:
- - Name of test material (as cited in study report): Nonanal
- Molecular formula: C₉H₁₈O
- Molecular weight: 397.09
- Smiles notation: CCCCCCCCC=O
- InChl: InChI=1S/C9H18O/c1-2-3-4-5-6-7-8-9-10/h9H,2-8H2,1H3
- Structural formula attached as image file.
- Appearance: Clear liquid
- Lot No.: 2F4107
- Expiration date of the lot/batch: 2003-03
- Storage condition of test material: room temperature in the dark
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): C9 aldehyde, C-192 (SN 2188-2)
- Molecular weight (if other than submission substance): 142.24
- Smiles notation (if other than submission substance): O=CCCCCCCCC
- Substance type: Clear, colourless liquid
- Physical state: Liquid
- Analytical purity: No data
- Impurities (identity and concentrations): No data
- Composition of test material, percentage of components: No data
- Isomers composition: No data
- Purity test date: No data
- Lot/batch No: No data
- Expiration date of the lot/batch: No data
- Stability under test conditions: No data
- Storage condition of test material: Room temperature under a blanket of nitrogen to avoid deterioration due to oxidation.
Method
- Target gene:
- TK
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat S-9 liver homogenate
- Test concentrations with justification for top dose:
- Without metabolic activation: 0 (control), 0.0977 nL/mL, 0.195 nL/mL, 6.25 nL/mL, 12.5 nL/mL, 25 nL/mL
With metabolic activation: 0 (control), 0.0977 nL/mL, 0.195 nL/mL, 6.25 nL/mL, 12.5 nL/mL, 25 nL/mL, 50 nL/mL, 60 nL/mL, 75 nL/mL, 100 nL/mL, 120 nL/mL. - Vehicle / solvent:
- - Vehicle/solvent used: DMSO
- Justification for choice of solvent/vehicle: Was immiscible in water at 100 µL/mL but dissolved in DMSO at that concentration.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- Concentration: 0.5 µL/L; without metabolic activation only
- Positive controls:
- yes
- Positive control substance:
- N-dimethylnitrosamine
- Remarks:
- Concentration: 0.3 µL/L; with metabolic activation only
- Details on test system and experimental conditions:
INDICATOR CELLS
- Mouse lymphoma cell line was derived from the Fischer L5178Y line of Dr Donald Clive.
- Stocks were maintained in liquid nitrogen and laboratory cultures were periodically checked for the absence of mycoplasma contamination by culturing methods
- To reduce the negative control frequency (spontaneous frequency) of TK-/- mutants to as low as possible, cell cultures were exposed to conditions that selected against the TK-/- phenotype (exposure to methotrexate) and are then returned to normal growth medium for ≥ 3 d before use.
MEDIA
- Cells were maintained in Fischer's mouse leukaemia medium supplemented with L-glutamine, sodium pyruvate and horse serum (10 % by volume).
- Cloning medium consisted of the preceding growth medium with the addition of agar to a final concentration of 0.35 % to achieve a semi-solid state.
- Selection of medium is cloning medium containing 100 µg/mL of BrdU or 3 µg/mL of TFT.
DOSE SELECTION
- A wide range of chemical concentrations was tested for cytotoxicity, starting with a maximum applied dose of 1 mg/mL for solutions in organic solvents.
- After a 4 hr exposure, the cells were washed and a viable count was obtained the next day.
- Relative cytotoxicities expressed as the reduction in growth compared to the growth of untreated cells was used to select 7 to 10 doses that cover the range from 0% to 50-90 % reduction in 24 hr. These selected doses were subsequently applied to cell cultures prepared for mutagenicity testing, but only 4 or 5 of the doses would be carried through to the mutant selection process. This procedure compensated for daily variations in cellular cytotoxicity and ensured that the choice of 4 or 5 doses spaced from 0 to 50- 90 % reduction in cell growth.
MUTAGENICITY TESTING
- Cultures exposed to the test chemical for 4 hrs at the pre-selected doses were washed and placed in growth medium for 2-3 d to allow recovery, gworth and expression of the TK-/- genotype. Cell counts were determined daily and appropriate dilutions were made to allow optimal growth rates.
- At the end of the expression period, 3 × 10⁶ cells for each selected dose were seeded in soft agar plates with selection medium and resistant (mutant) colonies were counted after 10 d incubation. To determine the actual number of cells capable of forming colonies, a portion of the cell suspension was also cloned in a normal, non-selective, medium. The ratio of resistant colonies to total viable cell number is the mutant frequency.
- A detailed flow diagram of the mutation assay is attached under supporting information below.
- The non-activation assay was run as described as above.
- The activation assay was run concurrently with the non-activation assay. The only difference is the addition of the S-9 fraction of rat liver homogenate and necessary cofactors (CORE) during the 4 hr treatment period. CORE consists of NADP (sodium salt) and isocitric acid. The final concentrations of the activation system component in the cell suspension were: 2.4 mg NADP/mL, 4.5 mg isocitric acid/mL and 50 µg S-9/mL.
PREPARATION OF S-9 LIVER HOMOGENATE
- A 9000 × g supernatant prepared from Fischer 344 adult male rat liver induced by Aroclor 1254 (described by Ames et al. 1975) was purchased from Bionetics Laboratory Products, Litton Bionetics, Inc.- Evaluation criteria:
- A test is considered positive (mutagenic) if:
- The mutation frequency exceeds 150 % of the concurrent background frequency by ≥ 10⁻⁴, and:
-- A dose-related or toxicity-related increase in mutant frequency, preferably in ≥ 3 doses.
-- Or, if an increase of ~ 2 × the minimum criterion or greater is observed for a single dose near the highest testable toxicity.
-- However, if an increase in mutant frequency is followed by only small or no further increase in toxicity, and there is a decrease in mutant frequency to values below the minimum criterion is not acceptable to classify the substance as mutagenic.
-- Either parameter, applied concentration or toxicity can be used to establish whether the mutagenic activity is related to an increase in effective treatment. A negative correlation with dose is acceptable only if a positive correlation with toxicity exists. An apparent increase in mutagenic activity as a function of decreasing toxicity is not acceptable evidence for mutagenicity.
A test is considered negative (non-mutagenic) if:
- If the minimum increase in frequency is not observed for a range of applied concentrations that extends to toxicity causing 5 % to 10 % relative suspension growth. - Statistics:
- None
Results and discussion
Test resultsopen allclose all
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- tested up to highest dose of 50 nL/mL
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: Appeared to be soluble up to 125 nL/mL but cloudiness that was indicative of immiscible droplets was observed from 250 nL/mL to 1000 nL/mL.
RANGE-FINDING/SCREENING STUDIES:
- 24 hr growth was severely reduced by exposure to 31 nL/mL and treatments with 62.5 nL/mL and higher were completely lethal. Therefore, the mutation assay was initiated with a series of concentrations from 50 nL/mL to 0.0977 nL/mL in 2-fold dilution steps to cover a wide range of toxic action.
NON-ACTIVATION CONDITIONS
- A single assay was performed under non-activation conditions, the results of which are given in table 1 in the attached supporting information.
- Under non-activation conditions, the mutant frequencies in the cultures remained strictly comparable to the negative (solvent and untreated) controls. The assayed treatments caused weak to moderate toxicities that resulted in a relative growth range of 69.8 % to 21.8 %. The toxicity was not closely related to the applied concentration, although the 25 nL/mL was the most toxic. Treatment with 50 nL/mL was completely toxic to the cells. A concentration approaching excessive lethality was closely approached without there obtaining any evidence of mutagenic activity. The test material was therefore evaluated as non-mutagenic under these conditions.
ACTIVATION CONDITIONS
- Three assays were performed under activation conditions, the details of which are given in tables 2-4 in the attached supporting information.
- In the first assay with metabolic activation (table 2), concentrations up to 120 nL/mL were examined. The exposure to 120 nL/mL was highly toxic (6.1 % relative growth), and treatment with 150 nL/mL was completely lethal. Increases in mutant frequency were observed for the 100 nL/mL and 120 nL/mL treatments that appeared to indicate weak mutagenic activity. However, the very low negative control values mutant frequencies introduced uncertainty into the calculation of the frequency of 21.9 × 10⁻⁶ as the minimum criterion for indicating mutagenesis. This frequency was just exceeded for the culture exposed to 100 nL/mL and closely approached by the 120 nL/mL treatment. Also, since the DMN positive control induced a mutant frequency just below the usual lower limit of 200 × 10⁻⁶, the activation efficiency of the S-9 mix may have been subnormal. Thus, a larger mutagenic increase might be observed for the test material in another trial where DMN activation was normal. Another trial was also necessary to determine whether the small increases were spurious or could be confirmed.
- In the 2nd assay with metabolic activation (table 3), good activation of DMN was demonstrated. Small increases in mutant frequency were observed for treatments in the 25 to 120 nL/mL range. The minimum criterion for indicating mutagenesis in this trial was a mutant frequency of 46.8 × 10⁻⁶. This value was exceeded in 3 cultures and closely approached in 2 others. The increases tended to correlated with increased frequency; thus the 6.25 nL/mL treatment, which caused 36.4 % relative growth, did not result in a significant change in mutant frequency. Treatment with 25 nL/mL (24.1 % relative growth) induced a 1.9 × increase over background. The four treatments from 60 nL/mL to 120 nL/mL were about equally toxic (10 to 15 % relative growth) and induced a 1.2 × increase. These results indicated a weak mutagenic activity associated with high toxicity and apparently reaching saturation at concentrations below 120 nL/mL. This saturation could be caused by the solubility limit since the presence of fine droplets of test material could be difficult to detect in the cloudy culture media and higher concentrations did result in noticeable cloudiness. The results from trials 2 and 3 were considered confirmatory and indicative of weak mutagenic activity for ≥ 1 product(s) of the test material formed by rat S-9 mix. Based on the new guidance for assessment of mouse lymphoma data, this study is considered to be negative.
- The average cloning efficiencies for the negative controls varied from 86 % without activation to 75 % (table 1) and 82 % (table 3) with activation, which demonstrated good culturing conditions for the assays. The negative control mutant frequencies were normal (but low in trial 2), and the positive control compounds induced mutant frequencies that were generally in excess of the backgrounds. - Remarks on result:
- other: strain/cell type: mouse lymphoma L5178Y cells
Applicant's summary and conclusion
- Conclusions:
- The test substance was assessed for genotoxicity in a mouse lymphoma assay with and without metabolic activation. The results of the test were negative with and without metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.